ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly effect of exchange rate changes on cash and equivalents ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
372
Period ended Dec 31, 2025
Change on a year earlier
-225.3%
-297 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Effect of exchange rate changes on cash and equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 372 | -225.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | -297 | -275.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 169 | -200.8% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | -168 | -18.5% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | -206 | -195.2% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 216 | -340.3% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | -89.9 | +41.4% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | -63.6 | +210.2% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | -20.5 | -91.3% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | -236 | +176.2% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | -85.6 | -74.9% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | -342 | +1,488.4% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | -21.5 | -149.0% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 43.9 | -139.6% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | -111 | -23.4% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | -145 | -770.4% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 21.6 | -122.4% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | -96.6 | -174.5% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 130 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Effect of exchange rate changes on cash and equivalents ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_fx_cash
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.